Halil Yıldız
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Parvovirus B19 Infection Studies
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
- Epidemiology 16
-
- Parvovirus B19 Infection Studies 4
- COVID-19 Clinical Research Studies 4
- Co-authors
- Jean Cyr Yombi (25 shared papers)Jérôme Razanamahery (2 shared papers)Rushad Patell (2 shared papers)Marie Christiane Vekemans (2 shared papers)Abi Vijenthira (2 shared papers)Fernando Martín‐Moro (2 shared papers)Thomas A. Fox (2 shared papers)Ioannis Mantzaris (2 shared papers)
- Journals
- Research and Practice in Thrombosis and Haemostasis (2 papers)Frontiers in Neurology (2 papers)Respiratory Medicine (2 papers)Blood (2 papers)Acta Clinica Belgica (11 papers)
- Partner nations
- BelgiumTürkiyeUnited States
In The Last Decade
Halil Yıldız
55 papers receiving 799 citations
Halil Yıldız's Hit Papers
Peers
Comparison fields: 5 of 79
- Infectious Diseases 419
- Neurology 185
- Hematology 122
- Oncology 264
- Critical Care and Intensive Care Medicine 34
Countries citing papers authored by Halil Yıldız
This map shows the geographic impact of Halil Yıldız's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil Yıldız with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil Yıldız more than expected).
Fields of papers citing papers by Halil Yıldız
This network shows the impact of papers produced by Halil Yıldız. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil Yıldız. The network helps show where Halil Yıldız may publish in the future.
Co-authors
The 25 scholars most cited alongside Halil Yıldız, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients Hit paper breakdown → | 2020 | 330 |
| 2 | 2021 | 77 | |
| 3 | 2021 | 44 | |
| 4 | 2020 | 44 | |
| 5 | 2021 | 24 | |
| 6 | 2024 | 20 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 17 | |
| 9 | 2017 | 17 | |
| 10 | 2019 | 17 | |
| 11 | 2019 | 15 | |
| 12 | 2021 | 15 | |
| 13 | 2022 | 14 | |
| 14 | 2021 | 14 | |
| 15 | 2022 | 13 | |
| 16 | 2019 | 13 | |
| 17 | 2016 | 12 | |
| 18 | 2018 | 8 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 6 |
About Halil Yıldız
Halil Yıldız is a scholar working on Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine, Rheumatology and Physiology, having authored 66 papers that have together received 814 indexed citations. Recurring topics across this work include Sarcoidosis and Beryllium Toxicity Research (9 papers), Infectious Diseases and Tuberculosis (5 papers), Vasculitis and related conditions (4 papers), Parvovirus B19 Infection Studies (4 papers), COVID-19 and healthcare impacts (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). The work is most often cited by research in Infectious Diseases (419 citations), Neurology (185 citations), Hematology (122 citations), Oncology (264 citations) and Critical Care and Intensive Care Medicine (34 citations). Halil Yıldız has collaborated with scholars based in Belgium, Türkiye and United States. Frequent co-authors include Jean Cyr Yombi, Jérôme Razanamahery, Rushad Patell, Marie Christiane Vekemans, Abi Vijenthira, Fernando Martín‐Moro, Thomas A. Fox, Ioannis Mantzaris, Thomas Chatzikonstantinou and Lydia Scarfò. Their work appears in journals such as Research and Practice in Thrombosis and Haemostasis, Frontiers in Neurology, Respiratory Medicine, Blood and Acta Clinica Belgica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.